712 related articles for article (PubMed ID: 28904096)
1. RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.
Ofengeim D; Mazzitelli S; Ito Y; DeWitt JP; Mifflin L; Zou C; Das S; Adiconis X; Chen H; Zhu H; Kelliher MA; Levin JZ; Yuan J
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):E8788-E8797. PubMed ID: 28904096
[TBL] [Abstract][Full Text] [Related]
2. NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.
Manocha GD; Ghatak A; Puig KL; Kraner SD; Norris CM; Combs CK
J Alzheimers Dis; 2017; 58(3):775-787. PubMed ID: 28505967
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.
Rojanathammanee L; Floden AM; Manocha GD; Combs CK
J Neuroinflammation; 2015 Mar; 12():42. PubMed ID: 25889879
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
[TBL] [Abstract][Full Text] [Related]
5. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
6. Cystatin F (
Daniels MJD; Lefevre L; Szymkowiak S; Drake A; McCulloch L; Tzioras M; Barrington J; Dando OR; He X; Mohammad M; Sasaguri H; Saito T; Saido TC; Spires-Jones TL; McColl BW
Elife; 2023 Dec; 12():. PubMed ID: 38085657
[TBL] [Abstract][Full Text] [Related]
7. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice.
Latta CH; Sudduth TL; Weekman EM; Brothers HM; Abner EL; Popa GJ; Mendenhall MD; Gonzalez-Oregon F; Braun K; Wilcock DM
J Neuroinflammation; 2015 Mar; 12():41. PubMed ID: 25885682
[TBL] [Abstract][Full Text] [Related]
8. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
[TBL] [Abstract][Full Text] [Related]
9. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
10. Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice.
Cao LL; Guan PP; Zhang SQ; Yang Y; Huang XS; Wang P
J Neuroinflammation; 2021 Dec; 18(1):281. PubMed ID: 34861878
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
[TBL] [Abstract][Full Text] [Related]
12. Expression of Ripk1 and DAM genes correlates with severity and progression of Krabbe disease.
Cachón-González MB; Wang S; Cox TM
Hum Mol Genet; 2021 Nov; 30(22):2082-2099. PubMed ID: 34172992
[TBL] [Abstract][Full Text] [Related]
13. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
14. The adhesion and migration of microglia to β-amyloid (Aβ) is decreased with aging and inhibited by Nogo/NgR pathway.
Fang Y; Wang J; Yao L; Li C; Wang J; Liu Y; Tao X; Sun H; Liao H
J Neuroinflammation; 2018 Jul; 15(1):210. PubMed ID: 30029608
[TBL] [Abstract][Full Text] [Related]
15. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.
Krauthausen M; Kummer MP; Zimmermann J; Reyes-Irisarri E; Terwel D; Bulic B; Heneka MT; Müller M
J Clin Invest; 2015 Jan; 125(1):365-78. PubMed ID: 25500888
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
17. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.
Fu W; Vukojevic V; Patel A; Soudy R; MacTavish D; Westaway D; Kaur K; Goncharuk V; Jhamandas J
J Neuroinflammation; 2017 Oct; 14(1):199. PubMed ID: 28985759
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
[TBL] [Abstract][Full Text] [Related]
19. Microglia Demonstrate Local Mixed Inflammation and a Defined Morphological Shift in an APP/PS1 Mouse Model.
Holloway OG; King AE; Ziebell JM
J Alzheimers Dis; 2020; 77(4):1765-1781. PubMed ID: 32894243
[TBL] [Abstract][Full Text] [Related]
20. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
